Drug composition for treating cat jaundice and preparation method thereof

The technology of a composition and a medicine is applied in the field of pharmaceutical compositions for treating cat jaundice and the field of preparation thereof, and can solve the problems of inability to achieve therapeutic effects, limited treatment plans, slow removal of jaundice, etc., and achieves low cost, no drug residues, The effect of a short course of treatment

Inactive Publication Date: 2015-08-19
NEW HOPE LIUHE FEED
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The treatment options and drugs are limited, and the ideal treatment effect cannot be achieved. The long course of the disease is slow to remove jaundice.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0064] Example 1 Pharmaceutical composition 1

[0065] The embodiment of the present invention provides a pharmaceutical composition for treating jaundice in cats, which is made of the following raw materials in parts by weight: 26 parts by weight of Sai Kui, 24 parts by weight of Gallbladder, 21 parts by weight of White Horse Bone, 13 parts by weight of Malan Parts by weight, 22 parts by weight of Hemeng, 14 parts by weight of Ditus, 25 parts by weight of Mallow, 16 parts by weight of Pteris, 13 parts by weight of Amaranth, 20 parts by weight of leaking reed, 18 parts by weight of Yingshi, and holly 13 parts by weight, 15 parts by weight of red peony, 12 parts by weight of paeonol, 21 parts by weight of comb sword, 16 parts by weight of rush, 11 parts by weight of dandelion, 13 parts by weight of iris flower, 18 parts by weight of Toosendan, 14 parts by weight of tangerine peel part and Zhi Licorice 15 parts by weight.

[0066] Its preparation method comprises the following ...

Embodiment 2

[0070] Embodiment 2 pharmaceutical composition 2

[0071] The embodiment of the present invention provides a pharmaceutical composition for treating jaundice in cats, which is made of the following raw materials in parts by weight: 26 parts by weight of Sai Kui, 24 parts by weight of Gallbladder, 21 parts by weight of White Horse Bone, 13 parts by weight of Malan Parts by weight, 22 parts by weight of Hemeng, 14 parts by weight of Ditus, 25 parts by weight of Mallow, 16 parts by weight of Pteris, 13 parts by weight of Amaranth, 20 parts by weight of leaking reed, 18 parts by weight of Yingshi, and holly 13 parts by weight, 15 parts by weight of red peony, 12 parts by weight of paeonol, 21 parts by weight of comb sword, 16 parts by weight of rush, 11 parts by weight of dandelion, 13 parts by weight of iris flower, 18 parts by weight of Toosendan, 14 parts by weight of tangerine peel 15 parts by weight of Zhi Licorice, 10 parts by weight of amomum, 11 parts by weight of cardamom...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a drug composition for treating cat jaundice and a preparation method thereof. The drug composition contains the following raw herbal materials: Malvastrum coromandelianum, swertia mileensis, Serissa serissoides, Kalimeris indica, Aeschynomene indica, hypericum japonicum, Malva verticillata, phoenix-tail fern, Gomphrena celosioides Mart., Uniflower Swisscentaury roots, Rosa multiflora Thunb, pubescent holly roots, common peony roots, cortex moutan, lance triblema herb, Juncus effuses, dandelion, iris ensata thumb, szechwan Chinaberry fruit, pericarpium citri reticulatae and honey-fried licorice roots. The drug composition for treating cat jaundice has the beneficial effects of clearing heat and promoting diuresis, cooling blood and eliminating toxins, promoting blood circulation and dissipating blood stasis, inducing diuresis for treating stranguria and soothing liver and harmonizing stomach supplemented by tonifying spleen and stimulating appetite as well as promoting digestion and invigorating stomach, being capable of strengthening the body resistance to eliminate pathogenic factors and enhancing the disease resistance of sick cats, and being short in course of treatment, good in the curative effect, free of drug resistance or drug residue and low in cost.

Description

technical field [0001] The invention relates to the field of veterinary medicine, in particular to a pharmaceutical composition for treating cat jaundice and a preparation method thereof. Background technique [0002] Jaundice, also known as jaundice, commonly known as yellow disease, is a symptom of yellowing of mucous membranes and eyeball sclera caused by increased bilirubin concentration in the blood. Certain liver, gallbladder, and blood disorders often cause symptoms of jaundice. [0003] The key to the pathogenesis of jaundice is dampness. In terms of viscera, the spleen, stomach, liver and gallbladder are the main ones, and the spleen and stomach are often involved in the liver and gallbladder. The spleen governs the movement and transformation of dampness, such as improper diet, alcoholism, fat, sweetness, or exogenous pathogenic dampness and heat, which can lead to impaired spleen and stomach function and spleen dysfunction. If dampness obstructs the middle energ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/88A61P1/16
Inventor 胡莉萍王洪霞崔晨华
Owner NEW HOPE LIUHE FEED
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products